Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia.

AIM Clinical significance of plant homeodomain finger 2 (PHF2) expressions is explored in acute lymphoblastic leukemia (ALL) patients. METHODS mRNA level was examined by qPCR. The retroviral gene expression, shRNA knockdown and chromatin-immunoprecipitation are used to observe IKAROS regulation on PHF2 transcription. RESULTS PHF2 expression is significantly reduced in subsets of ALL patients, and PHF2 low expression correlates with leukemia cell proliferation and an elevation of several poor prognostic markers in B-cell ALL. IKAROS directly promotes PHF2 expression and patients with IKAROS deletion have significantly lower PHF2 expression. Casein kinase II (CK2) inhibitor significantly promotes PHF2 expression in an IKAROS-dependent manner, and casein kinase II inhibitor treatment also results in an increase of PHF2 expression and enrichment of IKAROS and H3K4me3 at PHF2 promoter in primary cells. CONCLUSION Our results demonstrate that the IKAROS promotes PHF2 expression, and suggest that PHF2 low expression works with the IKAROS gene deletion to drive oncogenesis of ALL.

[1]  Chunhua Song,et al.  Cellular signaling and epigenetic regulation of gene expression in leukemia , 2019, Advances in biological regulation.

[2]  P. Jedlicka,et al.  Biology and targeting of the Jumonji-domain histone demethylase family in childhood neoplasia: a preclinical overview , 2019, Expert opinion on therapeutic targets.

[3]  L. Szekely,et al.  Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia , 2018, Oncogenesis.

[4]  K. Moon,et al.  Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma , 2017, Journal of pathology and translational medicine.

[5]  Ji-Young Kim,et al.  Regulatory role of G9a and LSD1 in the Transcription of Olfactory Receptors during Leukaemia Cell Differentiation , 2017, Scientific Reports.

[6]  A. Ashworth,et al.  Marked for death: targeting epigenetic changes in cancer , 2017, Nature Reviews Drug Discovery.

[7]  C. Mullighan,et al.  Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia. , 2017, Experimental hematology.

[8]  R. Gale,et al.  Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia , 2016, Scientific Reports.

[9]  Y. Shang,et al.  Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis. , 2016, The Journal of clinical investigation.

[10]  Robert A. Weinberg,et al.  Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability , 2016, Science.

[11]  S. Armstrong,et al.  MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C. , 2016, The Journal of clinical investigation.

[12]  Q. Li,et al.  Epigenetic regulation of gene expression by Ikaros, HDAC1 and Casein Kinase II in leukemia , 2015, Leukemia.

[13]  A. Davidoff,et al.  Histone demethylases and their roles in cancer epigenetics. , 2016, Journal of medical oncology and therapeutics.

[14]  H. Ouyang,et al.  Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia* , 2015, The Journal of Biological Chemistry.

[15]  Y. Kawasawa,et al.  Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia , 2015, Oncotarget.

[16]  S. Armstrong,et al.  JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors , 2015, Genes & development.

[17]  G. Robertson,et al.  Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. , 2015, Blood.

[18]  Z. Ge,et al.  Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia , 2015, PloS one.

[19]  H. Ouyang,et al.  Protein Phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros‐mediated repression of TdT in thymocytes and T‐cell leukemia , 2014, Pediatric blood & cancer.

[20]  J. Ablain,et al.  Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia , 2014, International journal of cancer.

[21]  W. H. Kim,et al.  PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer , 2014, Oncogene.

[22]  R. Jaenisch,et al.  Contrasting roles for histone 3 lysine 27 demethylases in acute lymphoblastic leukemia , 2014, Nature.

[23]  Kristian Helin,et al.  Histone lysine demethylases as targets for anticancer therapy , 2013, Nature Reviews Drug Discovery.

[24]  Yuuki Imai,et al.  Epigenetic Regulation of Adipogenesis by PHF2 Histone Demethylase , 2013, Diabetes.

[25]  N. Perrimon,et al.  Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20. , 2012, Molecular cell.

[26]  R. Pieters,et al.  Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements , 2012, Haematologica.

[27]  R. Juergens.  Targeting epigenetic changes in non-small cell lung cancer , 2012 .

[28]  S. Mukherjee,et al.  Association of FANCC and PTCH1 with the Development of Early Dysplastic Lesions of the Head and Neck , 2012, Annals of Surgical Oncology.

[29]  Amy K. Erbe,et al.  Regulation of Ikaros function by casein kinase 2 and protein phosphatase 1. , 2011, World journal of biological chemistry.

[30]  Clifford A. Meyer,et al.  PKA-dependent regulation of the histone lysine demethylase complex PHF2–ARID5B , 2011, Nature Cell Biology.

[31]  Kevin K Dobbin,et al.  Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. , 2010, Blood.

[32]  Min Gyu Lee,et al.  Recognition of Histone H3K4 Trimethylation by the Plant Homeodomain of PHF2 Modulates Histone Demethylation* , 2010, The Journal of Biological Chemistry.

[33]  J. Downing,et al.  Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. , 2010, Blood.

[34]  K. Hung,et al.  Ikaros Stability and Pericentromeric Localization Are Regulated by Protein Phosphatase 1* , 2009, Journal of Biological Chemistry.

[35]  Satyabrata Sinha,et al.  Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: Pathological significance in early- and late-onset breast carcinoma , 2008, Molecular Cancer.

[36]  K. Helin,et al.  Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. , 2008, Genes & development.

[37]  D. Campana,et al.  Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. , 1985, Journal of immunology.